Arax Advisory Partners
MIST icon

Arax Advisory Partners’s Milestone Pharmaceuticals MIST Stock Holding History

Arax Advisory Partners’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Buy
+3,053
New +$4.88K ﹤0.01% 4648
2026
Q1 		– Sell
-1,591
Closed -$3.21K – 4128
2025
Q4 		$3.21K Buy
1,591
+514
+48% +$1.11K ﹤0.01% 3075
2025
Q3 		$2.15K Buy
+1,077
New +$1.89K ﹤0.01% 3098

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Arax Advisory Partners's MIST Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Milestone Pharmaceuticals (MIST) in Q2 2026: 3,053 shares worth $4.09K. The stake represents ﹤0.01% of the portfolio and ranks #4648 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in MIST as recently as Q4 2025.

Arax Advisory Partners first reported a position in MIST in Q3 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Arax Advisory Partners held 3,053 shares of Milestone Pharmaceuticals worth $4.09K as of Q2 2026.
  • Milestone Pharmaceuticals was a new Arax Advisory Partners position in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4648 holding.
  • Arax Advisory Partners first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.